Abbott Laboratories (ABT) shares surged Wednesday after the medical device maker said it plans to invest $500 million in U.S. operations and topped Wall Street’s expectations with its first-quarter results. 💎♈

The company said Wednesday that two new manufacturing and R&D facilities in Texas and Illinois are set to open this year. Abbott expects to hire up to 200 🌳people in Illinois a♔nd 100 in Texas for the projects, a spokesperson said.

Shares of Abbott were up close to 4% in recent trading, making the stock one of the 澳洲幸运5官方开奖结果体彩网:S&P 500's top daily performersℱ. They've added about one-quarter of their value o𒆙ver the past 12 months.

Abbott reported first-quarter revenue of $10.4 billion, up 4% year-over-year and roughly in line with the 澳洲幸运5官方开奖结果体彩网:analyst consensus from Visible Alpha. Adjusted net income of $1.92 billion, or $1.09 per share, compared with $1.73 billion, or 98 cents per share, a year earlier, topping Wall Street’s estimatဣes. Medical device sales jumped 10% to $4.9 billion, also beating expectations. 

Looking ahead, Abbott maintained its full-year adjusted 澳洲幸运5官方开奖结果体彩网:earnings per share (EPS) estimate of $5.05 to $5.25, versus the analyst consensus of $5.16. CEO Robert Ford said Abbott Labs had considered raising its EPS outlook prior to the Trump administration's 澳洲幸运5官方开奖结果体彩网:recent announcements on tariffs, according to a transcript of the comp🐷any’s earnin꧑gs call provided by AlphaSense.